Half of people who start taking the GLP-1 weight-loss drug Ozempic drop it within a year, a new study says. About 52% of people in Denmark prescribed semaglutide (Ozempic, Wegovy) for weight loss stopped taking it after one year, researchers reported Saturday at a meeting of…
Read Full Article (External Site)
